Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS)

被引:3
|
作者
Das, Soumitra [1 ]
Purushothaman, Sumesh T. [2 ]
Malathesh, B. C. [3 ]
机构
[1] NIMHANS, Dept Psychiat, Bengaluru, India
[2] GMC, Dept Psychiat, Trichur, India
[3] NIMHANS, Forens Psychiat, Bengaluru, India
关键词
D O I
10.1016/j.ajp.2017.07.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:31 / 32
页数:2
相关论文
共 50 条
  • [31] Managing an effective treatment of the neuroleptic malignant syndrome (NMS): a meta-analysis
    Reulbach, U
    Bleich, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S518 - S518
  • [32] A Case Report on Neuroleptic Malignant Syndrome (NMS): How to Approach an Early Diagnosis
    Paul, Tanya
    Karam, Alvina
    Paul, Trissa
    Loh, Hanyou
    Ferrer, Gerardo F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [34] Neuroleptic Malignant Syndrome (NMS) after Treatment with Metoclopramide - A Rare Case Report
    Acharya, Sourya
    Shukla, Samarth
    Andhale, Amol
    Annadatha, Akhilesh
    Gupte, Yash
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (41): : 3065 - 3066
  • [35] DEFYING DIAGNOSTIC ODDS: DIAGNOSING NEUROLEPTIC MALIGNANT SYNDROME (NMS) AMIDST CONFOUNDERS
    Aguilar, Al
    Nicastro, Olivia
    Yohannes-Tomicich, Joanna
    Ash, Philip
    Bradford, Leah
    Carr, Natalie
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [36] NEUROLEPTIC MALIGNANT SYNDROME (NMS): A RARE PRESENTATION INDUCED BY AN ANTIEMETIC - CASE REPORT
    Kashyap, Gursharan Lal
    Patel, Ashok G.
    PSYCHIATRIA DANUBINA, 2011, 23 : S43 - S45
  • [37] Citalopram overdose, serotonin toxicity, or Neuroleptic Malignant Syndrome?: Reply
    Aydin, N
    Anaç, A
    Çayköylü, A
    Akçay, F
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (07): : 658 - 659
  • [38] Re-emerging Neuroleptic Malignant Syndrome (NMS) without Reintroduced Neuroleptic in a Schizophrenia Patient: a Case Report
    Tunjungsari, D.
    Tiksnadi, A.
    MOVEMENT DISORDERS, 2019, 34 : S602 - S602
  • [39] CYP2D6 Hhal genotype and the neuroleptic malignant syndrome (NMS)
    Iwahashi, K
    Nakamura, K
    Suwaki, H
    Tsuneoka, Y
    Ichikawa, Y
    CLINICA CHIMICA ACTA, 1997, 265 (01) : 143 - 144
  • [40] NEUROLEPTIC MALIGNANT SYNDROME (NMS) WITH CLOZAPINE MONOTHERAPY AND BENIGN HYPERTHERMIA IN THE POST-NMS PERIOD WITH CLOZAPINE - 2 CASES
    VETTER, P
    PROPPE, D
    HOPPESEYLER, S
    NERVENARZT, 1991, 62 (01): : 55 - 57